The Story Behind Vaccine Maker Gritstone's Ch. 11

By Emily Lever · November 5, 2024, 10:16 PM EST

Vaccine maker Gritstone bio Inc. hit Chapter 11 after a tightening investment market left it starved of the capital it needed to keep doing its research into preventative treatments for cancer,...

To view the full article, register now.

Bankruptcy Scorecard

Summary

A vaccine developer focused on preventative treatments for cancer and HIV filed for bankruptcy with plans to find a buyer in Chapter 11 that will continue its research.

Case Number

24-bk-12305

Judge

Karen Owens

Venue

U.S. Bankruptcy Court for the District of Delaware

Capital Structure

Total Liabilities:

$100 million to $500 million

View Full Scorecard

Documents

Case Information

Case Title

Gritstone bio, Inc.

Case Number

1:24-bk-12305

Court

Delaware

Nature of Suit

Date Filed

October 10, 2024